These SNPs typically are common in the population and contribute modestly to increasing the risk for prostate cancer, in contrast to mutations in germ-line cancer predisposition genes such as BRCA2 or HOXB13 which have been shown to explain a fraction of prostate cancers related to a strong inherited predisposition [9],[10]. This evidence concerns the gene BRCA2 and prostate cancer.